Results 1 to 10 of about 11,658 (188)

Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction [PDF]

open access: yesAnnals of Clinical and Translational Neurology, 2020
Objective In metachromatic leukodystrophy, a lysosomal storage disorder due to decreased arylsulfatase A activity, hematopoietic stem cell transplantation may stop brain demyelination and allow remyelination, thereby halting white matter degeneration ...
Nicole I. Wolf   +15 more
doaj   +9 more sources

The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review. [PDF]

open access: yesEur J Med Res, 2023
Background Metachromatic leukodystrophy (MLD; OMIM 250100 and 249900) is a rare lysosomal storage disease caused by deficient arylsulfatase A activity, leading to accumulation of sulfatides in the nervous system.
Chang SC, Eichinger CS, Field P.
europepmc   +3 more sources

Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy

open access: yesAnnals of Clinical and Translational Neurology, 2023
Objective Metachromatic leukodystrophy is a lysosomal storage disease caused by deficient arylsulfatase A. It is characterized by progressive demyelination and thus mainly affects the white matter.
Murtadha Al‐Saady   +13 more
doaj   +2 more sources

Metachromatic Leukodystrophy

open access: yesPediatric Neurology Briefs, 1990
A ten year old girl with metachromatic leukodystrophy in whom neurophysiologic function and sulfatide metabolism had improved after she received a bone marrow transplant five years before is reported from the Bone Marrow Transplantation Program ...
J Gordon Millichap
doaj   +3 more sources

Metachromatic leukodystrophy

open access: yesMuller Journal of Medical Sciences and Research, 2013
Metachromatic leukodystrophy or Scholz′s disease is a rare disorder transmitted as an autosomal recessive trait, leading to demyelination and neurological impairment.
Prima Cheryl D′souza   +3 more
doaj   +2 more sources

Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches

open access: yesFrontiers in Medicine, 2020
Metachromatic leukodystrophy is a lysosomal storage disease, which is characterized by damage of the myelin sheath that covers most of nerve fibers of the central and peripheral nervous systems.
Alisa A. Shaimardanova   +8 more
doaj   +2 more sources

Atidarsagene autotemcel for metachromatic leukodystrophy

open access: yesDrugs of Today, 2023
Metachromatic leukodystrophy (MLD) is a rare autosomal recessive disorder of sphingolipid metabolism, due to a deficiency of the enzyme arylsulfatase A (ARSA). The main clinical signs of the disease are secondary to central and peripheral nervous system demyelination.
Messina, M, Gissen, P
openaire   +4 more sources

Metachromatic Leukodystrophy Presenting with Multiple Cranial Nerve and Lumbosacral Nerve Root Enhancement Without White Matter Changes. [PDF]

open access: yesNeurol Int
Background: Metachromatic leukodystrophy (MLD) is a rare autosomal recessive disorder that causes demyelination of both the central (CNS) and peripheral nervous systems (PNS). Objective: This study aims to report a unique MLD case presenting with cranial
Jauregui R   +4 more
europepmc   +2 more sources

Metachromatic Leukodystrophy Variants

open access: yesPediatric Neurology Briefs, 1993
Clinical, pathological, imaging, and genetic findings in a family with multiple allelic mutations of metachromatic leukodystrophy (MLD) are reported from McGill University, Montreal, and McMaster University, Hamilton, Canada.
J Gordon Millichap
doaj   +4 more sources

Lipidomic analysis identifies age-disease-related changes and potential new biomarkers in brain-derived extracellular vesicles from metachromatic leukodystrophy mice

open access: yesLipids in Health and Disease, 2022
Background Recent findings show that extracellular vesicle constituents can exert short- and long-range biological effects on neighboring cells in the brain, opening an exciting avenue for investigation in the field of neurodegenerative diseases ...
Melissa R. Pergande   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy